Goodguy

Investing in the Obesity Drug Basket

The difference for Qnexa may be the 500 calorie deficit. If I read Mr. Murphy's table correctly: if the other protocols didn't specify that the patient achieve a 500cal per day deficit via exercise or lowered intake or some combination, the Qnexa trial theoretically should be ahead of the others by a loss of 56/lbs avg per participant over the course of their trial, even without using the drug. This is the calculation-->>> -500 cal/day X 392 days = -196,000 cal/ (3500 cal per pound of fat) = -56lbs. . So in the Qnexa trial if the protocol was followed, even without the drug a 56 lb weight loss should have resulted on average per person.

Nice balanced analysis Mr. Murphy. All three companies should have a good run.
Disclosure: Long VVUS, ARNA

Electro-Optical Sciences: A Speculative Stock with Great Potential

I couldn't agree more. Check their web site for more information on how effective the MelaFind device is.


Disclosure: Long MELA